A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer
This study has been completed.
Study NCT00710762
Information provided by Boehringer Ingelheim Pharmaceuticals
First Received on July 3, 2008.
Last Updated on February 11, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
